Altered Threonine Tyrosine Kinase (TTK) Expression Is Associated With Adverse Clinical Outcomes in Breast Tumors: An in Silico Approach. RSD 2023, 12 (13), e40121344285. https://doi.org/10.33448/rsd-v12i13.44285.